SCHEMBL13235107

SCHEMBL13235107

Cc1sc(NC(=O)Nc2ccc(Cl)cc2)c(C(N)=O)c1C

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.78
MAPT P10636 6/20 0.78
ALDH1A1 P00352 6/20 0.78
MEN1 O00255 5/20 0.78
RAB9A P51151 5/20 0.78
NPC1 O15118 3/20 0.78
GAA P10253 2/20 0.78
SMN1; SMN2 Q16637 5/20 0.74
KDM4E B2RXH2 4/20 0.74
NPSR1 Q6W5P4 3/20 0.74
TP53 P04637 3/20 0.74
XBP1 P17861 1/20 0.74
HPGD P15428 2/20 0.69
POLB P06746 2/20 0.60
PPARG P37231 1/20 0.60
NCOA2 Q15596 1/20 0.60
NCOA1 Q15788 1/20 0.60
RXFP1 Q9HBX9 1/20 0.60
NFKB1 P19838 1/20 0.59
MAPK1 P28482 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18015404 0.82 MEN1 (0.55) KMT2AMAPTALDH1A1MEN1RAB9A
SCHEMBL17988255 0.80 ALDH1A1 (0.68) KMT2AMAPTALDH1A1MEN1RAB9A
SCHEMBL18902237 0.76 MEN1 (0.48) KMT2AMAPTALDH1A1MEN1RAB9A
SCHEMBL18902191 0.76 KCNH2 (0.48) KMT2AMAPTALDH1A1MEN1RAB9A
SCHEMBL17018746 0.75 SMN1; SMN2 (0.53) KMT2AMAPTALDH1A1MEN1RAB9A
SCHEMBL18902194 0.75 KCNH2 (0.59) KMT2AMAPTALDH1A1MEN1RAB9A
SCHEMBL7003934 0.75 ALDH1A1 (0.70) KMT2AMAPTALDH1A1MEN1RAB9A
SCHEMBL6999632 0.75 RAB9A (0.62) KMT2AMAPTALDH1A1MEN1RAB9A
SCHEMBL7673789 0.75 ALDH1A1 (0.62) KMT2AMAPTALDH1A1MEN1RAB9A
Hydrochloric Acid SCHEMBL16961628 0.75 KCNH2 (0.53) KMT2AMAPTALDH1A1MEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173917-A1 UREA DERIVATIVES AS ABL MODULATORS AMBIT BIOSCIENCES CORPORATION 2010-07-08 US disclosed
US-20100173917-A1 UREA DERIVATIVES AS ABL MODULATORS AMBIT BIOSCIENCES CORPORATION 2010-07-08 US disclosed
US-7750160-B2 Isoxazolyl urea derivatives as kinase modulators AMBIT BIOSCIENCES CORPORATION (US) 2010-07-06 US disclosed
US-7750160-B2 Isoxazolyl urea derivatives as kinase modulators AMBIT BIOSCIENCES CORPORATION (US) 2010-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173917-A1 UREA DERIVATIVES AS ABL MODULATORS ABL1, ABL2, BCR KMT2A 285/4885MAPT 1165/4885ALDH1A1 620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.